FDA.reportPublic FDA data

SENSORCAINE

Product NDC
63323-464
11-digit product format
633230464
Labeler code
63323
Product ID
63323-464_13a48007-3784-46f2-bd4d-da1004186b81
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
BUPIVACAINE HYDROCHLORIDE
Dosage form
INJECTION, SOLUTION
Route
EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL
Labeler
Fresenius Kabi USA, LLC
Application
NDA018304
Marketing category
NDA
Marketing start
2010-11-19
Substance
BUPIVACAINE HYDROCHLORIDE
Active strength
2.5 mg/mL
Pharmacologic classes
Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Orange Book products#

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N018304-001SENSORCAINEBUPIVACAINE HYDROCHLORIDE0.25%INJECTABLE / INJECTIONAPRLD, Approved before 1982
N018304-002SENSORCAINEBUPIVACAINE HYDROCHLORIDE0.5%INJECTABLE / INJECTIONAPRLD, Approved before 1982
N018304-003SENSORCAINEBUPIVACAINE HYDROCHLORIDE0.75%INJECTABLE / INJECTIONAPRLD, Approved before 1982
N018304-004SENSORCAINEBUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE0.5%;0.0091MG/MLINJECTABLE / INJECTIONAPRLD1983-09-02
N018304-005SENSORCAINEBUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE0.75%;0.0091MG/MLINJECTABLE / INJECTIONAPRLD1983-09-02

Therapeutic equivalence codes#

Application-product, TE code table
Application-productTE code
N018304-001AP
N018304-002AP
N018304-003AP
N018304-004AP
N018304-005AP

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SENSORCAINE MPFBUPIVACAINE HYDROCHLORIDEFresenius Kabi USA, LLCb6bfc04a-1868-4630-9ca1-8c027af97ce32024-11-18Boxed warning, Warnings, Adverse reactionsExact identifier
SENSORCAINE MPFBUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATEFresenius Kabi USA, LLCeb6d8fee-def4-4c96-9972-695e8cea8ea82024-10-15Boxed warning, Warnings, Adverse reactionsExact identifier
Sensorcaine MPFBUPIVACAINE HYDROCHLORIDEFresenius Kabi USA, LLCe700eb7b-8b14-49c9-96b2-331f18776e452023-05-12Boxed warning, Warnings, Adverse reactionsExact identifier
SENSORCAINE MPFBUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATEFresenius Kabi USA, LLCdcf3c0ad-9eb8-4ee7-96df-d0db7ff231752022-08-17Boxed warning, Warnings, Adverse reactionsExact identifier

Boxed warning cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

boxed warning

THE 0.75% CONCENTRATION OF SENSORCAINE INJECTION IS NOT RECOMMENDED FOR OBSTETRICAL ANESTHESIA. THERE HAVE BEEN REPORTS OF CARDIAC ARREST WITH DIFFICULT RESUSCITATION OR DEATH DURING USE OF BUPIVACAINE FOR EPIDURAL ANESTHESIA IN OBSTETRICAL PATIENTS. IN MOST CASES, THIS HAS FOLLOWED USE OF THE 0.75% CONCENTRATION. RESUSCITATION HAS BEEN DIFFICULT OR IMPOSSIBLE DESPITE APPARENTLY ADEQUATE PREPARATION AND APPROPRIATE MANAGEMENT. CARDIAC ARREST HAS OCCURRED AFTER CONVULSIONS RESULTING FROM SYSTEMIC TOXICITY, PRESUMABLY FOLLOWING UNINTENTIONAL INTRAVASCULAR INJECTION. THE 0.75% CONCENTRATION SHOULD BE RESERVED FOR SURGICAL PROCEDURES WHERE A HIGH DEGREE OF MUSCLE RELAXATION AND PROLONGED EFFECT ARE NECESSARY. LOCAL ANESTHETICS SHOULD ONLY BE EMPLOYED BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES WHICH MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED, AND THEN ONLY AFTER INSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY RESUSCITATIVE EQUIPMENT, AND THE PERSONNEL RESOURCES NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also ADVERSE REACTIONS , PRECAUTIONS , and OVERDOSAGE ). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST AND, POSSIBLY, DEATH. Local anesthetic solutions containing antimicrobial preservatives, i.e., those supplied in multiple-dose vials, should not be used for epidural or caudal anesthesia because safety has not been established with regard to intrathecal injection, either intentionally or unintentionally, of such preservatives. Intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures is an unapproved use, and there have been post-marketing reports of chondrolysis in patients receiving such infusions. The majority of reported cases of chondrolysis have involved the shoulder joint; cases of gleno-humeral chondrolysis have been described in pediatric and adult patients following intra-articular infusions of local anesthetics with and without epinephrine for periods of 48 to 72 hours. There is insufficient information to determine whether shorter infusion periods are not associated with these findings. The time of onset of symptoms, such as joint pain, stiffn...

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

warnings

WARNINGS: THE 0.75% CONCENTRATION OF SENSORCAINE INJECTION IS NOT RECOMMENDED FOR OBSTETRICAL ANESTHESIA. THERE HAVE BEEN REPORTS OF CARDIAC ARREST WITH DIFFICULT RESUSCITATION OR DEATH DURING USE OF BUPIVACAINE FOR EPIDURAL ANESTHESIA IN OBSTETRICAL PATIENTS. IN MOST CASES, THIS HAS FOLLOWED USE OF THE 0.75% CONCENTRATION. RESUSCITATION HAS BEEN DIFFICULT OR IMPOSSIBLE DESPITE APPARENTLY ADEQUATE PREPARATION AND APPROPRIATE MANAGEMENT. CARDIAC ARREST HAS OCCURRED AFTER CONVULSIONS RESULTING FROM SYSTEMIC TOXICITY, PRESUMABLY FOLLOWING UNINTENTIONAL INTRAVASCULAR INJECTION. THE 0.75% CONCENTRATION SHOULD BE RESERVED FOR SURGICAL PROCEDURES WHERE A HIGH DEGREE OF MUSCLE RELAXATION AND PROLONGED EFFECT ARE NECESSARY. LOCAL ANESTHETICS SHOULD ONLY BE EMPLOYED BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES WHICH MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED, AND THEN ONLY AFTER INSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY RESUSCITATIVE EQUIPMENT, AND THE PERSONNEL RESOURCES NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also ADVERSE REACTIONS , PRECAUTIONS , and OVERDOSAGE ). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST AND, POSSIBLY, DEATH. Local anesthetic solutions containing antimicrobial preservatives, i.e., those supplied in multiple-dose vials, should not be used for epidural or caudal anesthesia because safety has not been established with regard to intrathecal injection, either intentionally or unintentionally, of such preservatives. Intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures is an unapproved use, and there have been post-marketing reports of chondrolysis in patients receiving such infusions. The majority of reported cases of chondrolysis have involved the shoulder joint; cases of gleno-humeral chondrolysis have been described in pediatric and adult patients following intra-articular infusions of local anesthetics with and without epinephrine for periods of 48 to 72 hours. There is insufficient information to determine whether shorter infusion periods are not associated with these findings. The time of onset of symptoms, such as joint pa...

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

adverse reactions

ADVERSE REACTIONS: To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Reactions to Sensorcaine (bupivacaine HCl) are characteristic of those associated with other amide-type local anesthetics. A major cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, unintentional intravascular injection, or slow metabolic degradation. The most commonly encountered acute adverse experiences which demand immediate counter-measures are related to the central nervous system and the cardiovascular system. These adverse experiences are generally dose related and due to high plasma levels which may result from overdosage, rapid absorption from the injection site, diminished tolerance, or from unintentional intravascular injection of the local anesthetic solution. In addition to systemic dose-related toxicity, unintentional subarachnoid injection of drug during the intended performance of caudal or lumbar epidural block or nerve blocks near the vertebral column (especially in the head and neck region) may result in underventilation or apnea (“Total or High Spinal”). Also, hypotension due to loss of sympathetic tone and respiratory paralysis or underventilation due to cephalad extension of the motor level of anesthesia may occur. This may lead to secondary cardiac arrest if untreated. Patients over 65 years, particularly those with hypertension, may be at increased risk for experiencing the hypotensive effects of bupivacaine. Factors influencing plasma protein binding, such as acidosis, systemic diseases which alter protein production, or competition of other drugs for protein binding sites, may diminish individual tolerance. Central Nervous System Reactions These are characterized by excitation and/or depression. Restlessness, anxiety, dizziness, tinnitus, blurred vision, or tremors may occur, possibly proceeding to convulsions. However, excitement may be transient or absent, with depression being the first manifestation of an adverse reaction. This may quickly be followed by drowsiness merging into unconsciousness and respiratory arrest. Other central nervous system effects may be nausea, vomiting, chills, and constriction of the pupils. The incidence of convulsions associated with the use of local anesthetics varies with the proced...

Additional Listing Data#

Finished product
Yes
Brand name base
SENSORCAINE
Brand name suffix
MPF
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BUPIVACAINE HYDROCHLORIDE2.5 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii7TQO7W3VT8, 30Q7KI53AK
Rxcui1672917, 1672919, 1673296, 1673298, 1724880, 1724881, 1724884, 1724885, 1725078, 1725082, 1725175, 1725177

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0b4ec9ca-d305-43fc-88dd-7a510313efe0Product name120260105
bb209f42-a85f-4fee-9d3d-c9dded168625Product name120251208
49628fc7-2031-4c28-bd31-0ef3aa8f44a3Product name320251118
cbf85893-59ef-423f-87d4-a573c000a8b9Product name820250731
b5b1095b-40cd-8a9e-b111-502545045b07Product name420250325
e190029e-423b-473c-8e04-2ada59b5b711Product name120250314
5dad6767-dcd1-b0da-8727-7f3f7bc3a435Product name220250303
e0031c74-3853-42bc-8e10-86dbbe83992eProduct name220231116
f7046b89-2016-499a-adc6-78479172abc6Product name120230425
e3a99641-4540-4894-9108-00cab3c57b7eProduct name120211207
5da98533-f072-406b-9e1b-6ac19eca9926Product name120210622
306b993e-3140-4823-ad5e-88b708f9d2acProduct name120210510
a831e694-3663-4a83-82be-6c309429f750Product name220200608
2686d634-e712-4007-8dbf-3d37c6c4d71fProduct name120181121
fa8b5901-e681-426f-82fe-54f6d81ec698Product name420180619
bd49bb86-2d32-4a7a-a594-eeda2e29af42Product name120180118
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070Product name120171221
3becbe78-12d9-4ad2-9b4c-1e36f8d1303aProduct name120170815

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63323-464-02SENSORCAINEMPF30 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION3010
63323-464-03SENSORCAINEMPF30 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION3010
63323-464-31SENSORCAINEMPF5 in 1 BOXINJECTION, SOLUTION510
63323-464-37SENSORCAINEMPF25 in 1 TRAYINJECTION, SOLUTION2510
63323-464-01SensorcaineMPF10 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION107
63323-464-17SensorcaineMPF25 in 1 TRAYINJECTION, SOLUTION257
63323-464-08SENSORCAINEMPF10 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION101
63323-464-09SENSORCAINEMPF30 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION301
63323-464-38SENSORCAINEMPF25 in 1 TRAYINJECTION, SOLUTION251
63323-464-39SENSORCAINEMPF25 in 1 TRAYINJECTION, SOLUTION251

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63323-464-01ML - Milliliter63323-464a95009d7-4c76-43d9-a031-32de3733f02312021-09-07
63323-464-02ML - Milliliter63323-464ed5d75df-0557-4de0-be0d-b650577eb9cd12022-02-07
63323-464-08ML - Milliliter63323-464b9775b1b-7b08-44ff-a98c-ff02d368394612025-01-14
63323-464-09ML - Milliliter63323-4647fec3893-88a9-4e8e-93c9-ff52085ce48912024-11-05
63323-464-17ML - Milliliter63323-464018101d1-b391-4d43-a136-957d34adf59512012-07-24
63323-464-31ML - Milliliter63323-464fd4dff38-e949-491f-920d-8ed9e60e7ac812012-07-24
63323-464-33ML - Milliliter63323-464f9592b4f-7114-4d9a-a869-a2d296abbd2d12012-07-24
63323-464-37ML - Milliliter63323-46477835e45-e7a7-46f2-888e-7c68cad0a54c12012-07-24
63323-464-38ML - Milliliter63323-4648d957fa6-2077-461b-b74f-6e6b6839b4e212025-01-14
63323-464-39ML - Milliliter63323-4643e1e097f-d34f-4a38-90d4-c2c7a979768412024-11-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BUPIVACAINE HYDROCHLORIDEACTIVE INGREDIENT7TQO7W3VT8SENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
EPINEPHRINE BITARTRATEACTIVE INGREDIENT30Q7KI53AKSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
BUPIVACAINEACTIVE MOIETYY8335394ROSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
EPINEPHRINEACTIVE MOIETYYKH834O4BHSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32ISENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
SODIUM METABISULFITEINACTIVE INGREDIENT4VON5FNS3CSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
BUPIVACAINE HYDROCHLORIDEACTIVE INGREDIENT7TQO7W3VT8SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]4
BUPIVACAINEACTIVE MOIETYY8335394ROSENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]4
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBSENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]4
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XSENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]4
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32ISENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63323-464SENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]10Current NDC, Legacy NDC, 4 package rows20241031_eb6d8fee-def4-4c96-9972-695e8cea8ea8.zip
63323-464SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ]7Current NDC, Legacy NDC, 2 package rows20230630_e700eb7b-8b14-49c9-96b2-331f18776e45.zip
63323-464SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]1Current NDC, Legacy NDC, 2 package rows20241012_dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175.zip
63323-464SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]1Current NDC, Legacy NDC, 2 package rows20241222_b6bfc04a-1868-4630-9ca1-8c027af97ce3.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1725078BUPivacaine HCl 0.25 % in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725082BUPivacaine HCl 0.25 % in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012396BUPivacaine HCl 0.25 % Injectable SolutionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1672917BUPivacaine HCl 0.5 % / EPINEPHrine 1:200,000 in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1672919BUPivacaine HCl 0.5 % / EPINEPHrine 1:200,000 in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724880BUPivacaine HCl 0.5 % in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724884BUPivacaine HCl 0.5 % in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012404BUPivacaine HCl 0.5 % Injectable SolutionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012391BUPivacaine HCl 0.75 % / EPINEPHrine 1:200,000 in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725175Sensorcaine 0.25 % in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725177Sensorcaine 0.25 % in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012455Sensorcaine 0.25 % Injectable SolutionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1673298Sensorcaine 0.5 % / EPINEPHrine 1:200,000 in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724881Sensorcaine 0.5 % in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724885Sensorcaine 0.5 % in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012457Sensorcaine 0.5 % Injectable SolutionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012421Sensorcaine 0.75 % / EPINEPHrine 1:200,000 in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1673296Sensorcaine 5 % / EPINEPHrine 1:200,000 in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
172517510 ML bupivacaine hydrochloride 2.5 MG/ML Injection [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
167329610 ML bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML Injection [Sensorcaine with Epinephrine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488110 ML bupivacaine hydrochloride 5 MG/ML Injection [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172517730 ML bupivacaine hydrochloride 2.5 MG/ML Injection [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
167329830 ML bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML Injection [Sensorcaine with Epinephrine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488530 ML bupivacaine hydrochloride 5 MG/ML Injection [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
101242130 ML bupivacaine hydrochloride 7.5 MG/ML / epinephrine 0.005 MG/ML Injection [Sensorcaine with Epinephrine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012455bupivacaine hydrochloride 2.5 MG/ML Injectable Solution [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012457bupivacaine hydrochloride 5 MG/ML Injectable Solution [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172507810 ML bupivacaine hydrochloride 2.5 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
167291710 ML bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488010 ML bupivacaine hydrochloride 5 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172508230 ML bupivacaine hydrochloride 2.5 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
167291930 ML bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488430 ML bupivacaine hydrochloride 5 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
101239130 ML bupivacaine hydrochloride 7.5 MG/ML / epinephrine 0.005 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012396bupivacaine hydrochloride 2.5 MG/ML Injectable SolutionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012404bupivacaine hydrochloride 5 MG/ML Injectable SolutionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172517510 ML Sensorcaine 2.5 MG/ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488110 ML Sensorcaine 5 MG/ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
172517730 ML Sensorcaine 2.5 MG/ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488530 ML Sensorcaine 5 MG/ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725078bupivacaine HCl 0.25 % in 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725082bupivacaine HCl 0.25 % per 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1672917bupivacaine HCl 0.5 % / epinephrine (as bitartrate) 1:200,000 per 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1672919bupivacaine HCl 0.5 % / epinephrine (as bitartrate) 1:200,000 per 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724880bupivacaine HCl 0.5 % in 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724884bupivacaine HCl 0.5 % in 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012391bupivacaine HCl 0.75 % / epinephrine (as epinephrine bitartrate) 1:200,000 per 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012396bupivacaine hydrochloride 0.25 % Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012404bupivacaine hydrochloride 0.5 % Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012455Sensorcaine 0.25 % Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1673298Sensorcaine 0.5 % / epinephrine (as bitratrate) 1:200,000 in 30 mL InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012457Sensorcaine 0.5 % Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012455Sensorcaine 2.5 MG/ML Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1673296Sensorcaine 5 % / EPINEPHrine 1:200,000 per 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012457Sensorcaine 5 MG/ML Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012421Sensorcaine with Epinephrine 0.75 % / 1:200,000 (bupivacaine hydrochloride / epinephrine (as epinephrine bitartrate) ) per 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725175Sensorcaine-MPF 0.25 % in 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725177Sensorcaine-MPF 0.25 % in 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724881Sensorcaine-MPF 0.5 % in 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724885Sensorcaine-MPF 0.5 % in 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012421Sensorcaine-MPF 0.75 % / epinephrine 1:200,000 per 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725078BUPivacaine HCl 0.25 % in 10 ML InjectionPSNe700eb7b-8b14-49c9-96b2-331f18776e457
1724880BUPivacaine HCl 0.5 % in 10 ML InjectionPSNe700eb7b-8b14-49c9-96b2-331f18776e457
1725175Sensorcaine 0.25 % in 10 ML InjectionPSNe700eb7b-8b14-49c9-96b2-331f18776e457
1724881Sensorcaine 0.5 % in 10 ML InjectionPSNe700eb7b-8b14-49c9-96b2-331f18776e457
172517510 ML bupivacaine hydrochloride 2.5 MG/ML Injection [Sensorcaine]SBDe700eb7b-8b14-49c9-96b2-331f18776e457
172488110 ML bupivacaine hydrochloride 5 MG/ML Injection [Sensorcaine]SBDe700eb7b-8b14-49c9-96b2-331f18776e457
172507810 ML bupivacaine hydrochloride 2.5 MG/ML InjectionSCDe700eb7b-8b14-49c9-96b2-331f18776e457
172488010 ML bupivacaine hydrochloride 5 MG/ML InjectionSCDe700eb7b-8b14-49c9-96b2-331f18776e457
172517510 ML Sensorcaine 2.5 MG/ML InjectionSYe700eb7b-8b14-49c9-96b2-331f18776e457
172488110 ML Sensorcaine 5 MG/ML InjectionSYe700eb7b-8b14-49c9-96b2-331f18776e457
1725078bupivacaine HCl 0.25 % in 10 ML InjectionSYe700eb7b-8b14-49c9-96b2-331f18776e457
1724880bupivacaine HCl 0.5 % in 10 ML InjectionSYe700eb7b-8b14-49c9-96b2-331f18776e457
1725175Sensorcaine-MPF 0.25 % in 10 ML InjectionSYe700eb7b-8b14-49c9-96b2-331f18776e457
1724881Sensorcaine-MPF 0.5 % in 10 ML InjectionSYe700eb7b-8b14-49c9-96b2-331f18776e457
1725078BUPivacaine HCl 0.25 % in 10 ML InjectionPSNdcf3c0ad-9eb8-4ee7-96df-d0db7ff231751
1725078BUPivacaine HCl 0.25 % in 10 ML InjectionPSNb6bfc04a-1868-4630-9ca1-8c027af97ce31
1725082BUPivacaine HCl 0.25 % in 30 ML InjectionPSNb6bfc04a-1868-4630-9ca1-8c027af97ce31
1725082BUPivacaine HCl 0.25 % in 30 ML InjectionPSNdcf3c0ad-9eb8-4ee7-96df-d0db7ff231751
1672917BUPivacaine HCl 0.5 % / EPINEPHrine 1:200,000 in 10 ML InjectionPSNdcf3c0ad-9eb8-4ee7-96df-d0db7ff231751

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63323-464-016332304640110 mL in 1 VIAL, SINGLE-DOSE10 mlHistorical
63323-464-026332304640230 mL in 1 VIAL, SINGLE-DOSE30 mlHistorical
63323-464-036332304640330 mL in 1 VIAL, SINGLE-DOSE30 mlHistorical
63323-464-086332304640810 mL in 1 VIAL, SINGLE-DOSE10 mlHistorical
63323-464-096332304640930 mL in 1 VIAL, SINGLE-DOSE30 mlHistorical
63323-464-176332304641725 VIAL, SINGLE-DOSE in 1 TRAY (63323-464-17) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-464-01) 2010-11-190000-00-00NoNoCurrent
63323-464-31633230464315 VIAL, SINGLE-DOSE in 1 BOX (63323-464-31) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-464-03) 2010-11-190000-00-00NoNoCurrent
63323-464-376332304643725 VIAL, SINGLE-DOSE in 1 TRAY (63323-464-37) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-464-02) 2010-11-190000-00-00NoNoCurrent
63323-464-386332304643825 VIAL, SINGLE-DOSE in 1 TRAY (63323-464-38) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-464-08) 2022-07-29NoNoCurrent
63323-464-396332304643925 VIAL, SINGLE-DOSE in 1 TRAY (63323-464-39) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-464-09) 2022-07-29NoNoCurrent